About 9 results found for searched term "57-63-6" (0.052 seconds)
Cat.No. | Name | Target |
---|---|---|
M2551 | LY573636 (Tasisulam) | Caspase |
Tasisulam | ||
LY573636 is a novel anticancer agent that induces apoptosis through the intrinsic pathway and has antiangiogenic activity in preclinical models. | ||
M3392 | Ethinyl Estradiol | Estrogen Receptor |
17α-Ethynylestradiol; Ethynylestradiol | ||
Ethinyl Estradiol (Ethinylestradiol) is an orally bio-active estrogen used in almost all modern formulations of combined oral contraceptive pills. | ||
M3396 | NVP-BVU972 | c-Met |
NVP-BVU972 is a selective and potent Met inhibitor with IC50 of 14 nM. | ||
M14338 | 1-Methyladenosine | Metabolite/Endogenous Metabolite |
1-Methyladenosine is an RNA modification originating essentially from two different reaction types, one catalyzed by enzymes and the other the result of the reaction of RNA with certain alkylating agents. | ||
M22013 | Cicloxilic acid | Others |
Cicloxilic acid | ||
M28387 | SBP-0636457 | IAP |
SBI-0636457; SB1-0636457 | ||
SBP-0636457 (SB1-0636457) is a SMAC mimetic, and as an IAP antagonist. SBP-0636457 binds to the BIR-domains of the IAP proteins, with a Ki of 0.27 μM. SBP-0636457 can be used for the research of solid tumors and hematologic cancers. | ||
M30230 | Tasisulam sodium | Apoptosis |
LY 573636 sodium | ||
Tasisulam is a anticancer agent and induces apoptosis via the intrinsic pathway, resulting in cytochrome c release and caspase-dependent cell death. Tasisulam inhibits mitotic progression and induces vascular normalization. | ||
M30708 | Patentiflorin A | HIV Protease |
Patentiflorin A is a potent, broadspectrum HIV-1 inhibitor. Patentiflorin A also inhibits HIV drug-resistant strains. | ||
M51264 | Proteasome-activating peptide 1 | Others |
Proteasome-activating peptide 1 is a peptide, which increases the chymotrypsin-like proteasomal catalytic activity and, consequently, proteolytic rates both in vitro and in culture. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.